Clinical trial

Effect of Pioglitazone on Left Ventricular Diastolic Function in Type 2 Diabetes Mellitus

NCT00232362

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2007-06-01

PhasePHASE1

Study timeline

Study start (unknown)2007-06-01Date precision: month

Registry last updated2015-04-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetes Mellitusunresolved

Interventions

Pioglitazone (Actos)DRUG

Anti-diabetic agent other than pioglitazone or rosiglitazoneDRUG

Sponsors & collaborators

Texas Tech University Health Sciences Centerlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00232362 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.